NCT06700616 A Study in Patients With Myasthenia Gravis in China Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis Status RECRUITING Phase PHASE1
NCT06659627 Interventions Against Fatigue in Patients With Myasthenia Gravis Status RECRUITING Phase NA
NCT06626919 A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases Status RECRUITING Phase PHASE1
NCT06624345 Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization Status COMPLETED Phase NA
NCT06617741 Myasthenia Gravis Foundation of America Global MG Patient Registry Status RECRUITING Phase N/A
NCT06605612 Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders Status ENROLLING_BY_INVITATION Phase N/A
NCT06539169 FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases Status RECRUITING Phase N/A
NCT06501794 Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients Status COMPLETED Phase NA
NCT06491238 Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis Status RECRUITING Phase NA
NCT06443333 National, Multicentric Registry Study on Neuroimmunological Diseases in China Status RECRUITING Phase N/A
NCT06441825 Patient Observation With Environmental and Wearable Sensors in Myasthenia Gravis Status RECRUITING Phase N/A
NCT06414954 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis Status RECRUITING Phase PHASE2
NCT06381284 Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment Status COMPLETED Phase N/A
NCT06371040 Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis Status RECRUITING Phase PHASE1
NCT06299748 A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding. Status RECRUITING Phase N/A
NCT06298565 A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa Status RECRUITING Phase N/A
NCT06298552 A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis Status ACTIVE_NOT_RECRUITING Phase PHASE3